Literature DB >> 28720517

Transient receptor potential TRPM3 channels: Pharmacology, signaling, and biological functions.

Gerald Thiel1, Sandra Rubil2, Andrea Lesch2, Lisbeth A Guethlein3, Oliver G Rössler2.   

Abstract

The transient receptor potential melastatin-3 (TRPM3) channel belongs to the family of transient receptor potential (TRP) cation channels that are expressed in a variety of tissues and cell types, including dorsal root ganglia, cardiomyocytes and pancreatic beta-cells. Although its natural ligands are currently unknown, TRPM3 channels can be activated by the neurosteroid pregnenolone sulfate, the synthetic ligand CIM0216, and by noxious heat. TRPM3 channels are regulated by phosphoinositides, and perhaps by calmodulin. Stimulation of TRPM3 induces an intracellular signaling cascade involving a rise in intracellular Ca2+, activation of the protein kinases Raf, ERK and JNK, and the activation of the stimulus-responsive transcription factors AP-1, CREB, Egr-1, and Elk-1. Functionally, stimulation of TRPM3 channels is connected with heat sensation by somatosensory neurons, insulin secretion by pancreatic beta-cells, regulation of neurotransmitter release, iris constriction, and tumor promotion. With the development of highly specific activators and inhibitors of TRPM3 channels, we expect that additional tissue-specific functions of TRPM3 channels will be discovered, establishing TRPM3 channels as a new therapeutic target.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CIM 0216 (PubChem CID: 42887770); Calcium channel; Heat sensation; Isosakuranetin (PubChem CID 160481); Mefenamic acid (PubChem CID: 4044); Pain; Pregnenolone sulfate; Pregnenolone sulfate (PubChem CID: 105074); TRPM3; Tumor promotion; eriodictyol (PubChem CID: 440735); hesperetin (PubChem CID: 72281); liquiritigenin (PubChem CID:114829); naringenin (PubChem CID: 932); primidone (PubChem CID: 4909)

Mesh:

Substances:

Year:  2017        PMID: 28720517     DOI: 10.1016/j.phrs.2017.07.014

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  11 in total

Review 1.  TRPM3_miR-204: a complex locus for eye development and disease.

Authors:  Alan Shiels
Journal:  Hum Genomics       Date:  2020-02-18       Impact factor: 4.639

2.  Association of protein function-altering variants with cardiometabolic traits: the strong heart study.

Authors:  Yue Shan; Shelley A Cole; Karin Haack; Phillip E Melton; Lyle G Best; Christopher Bizon; Sayuko Kobes; Çiğdem Köroğlu; Leslie J Baier; Robert L Hanson; Serena Sanna; Yun Li; Nora Franceschini
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

3.  TRPM3 expression and control of glutamate release from primary vagal afferent neurons.

Authors:  Forrest J Ragozzino; Rachel A Arnold; Axel J Fenwick; Timothy P Riley; Jonathan E M Lindberg; BreeAnne Peterson; James H Peters
Journal:  J Neurophysiol       Date:  2020-12-09       Impact factor: 2.714

4.  The TRPP2-dependent channel of renal primary cilia also requires TRPM3.

Authors:  Steven J Kleene; Brian J Siroky; Julio A Landero-Figueroa; Bradley P Dixon; Nolan W Pachciarz; Lu Lu; Nancy K Kleene
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

5.  Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study.

Authors:  Cecilia Rustichelli; Elisa Bellei; Stefania Bergamini; Emanuela Monari; Flavia Lo Castro; Carlo Baraldi; Aldo Tomasi; Anna Ferrari
Journal:  J Headache Pain       Date:  2021-03-23       Impact factor: 7.277

6.  Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.

Authors:  Natalie Eaton-Fitch; Stanley Du Preez; Hélène Cabanas; Katsuhiko Muraki; Donald Staines; Sonya Marshall-Gradisnik
Journal:  J Transl Med       Date:  2022-02-16       Impact factor: 5.531

7.  Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.

Authors:  Etianne Martini Sasso; Katsuhiko Muraki; Natalie Eaton-Fitch; Peter Smith; Olivia Ly Lesslar; Gary Deed; Sonya Marshall-Gradisnik
Journal:  Mol Med       Date:  2022-08-19       Impact factor: 6.376

8.  Expression of the C-Terminal Domain of Phospholipase Cβ3 Inhibits Signaling via Gαq-Coupled Receptors and Transient Receptor Potential Channels.

Authors:  Gerald Thiel; Oliver G Rössler
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

Review 9.  A new molecular risk pathway for postpartum mood disorders: clues from steroid sulfatase-deficient individuals.

Authors:  Harish Thippeswamy; William Davies
Journal:  Arch Womens Ment Health       Date:  2020-11-20       Impact factor: 3.633

10.  The Impact of Steroid Activation of TRPM3 on Spontaneous Activity in the Developing Retina.

Authors:  Corey M Webster; Joshua Tworig; Franklin Caval-Holme; Catherine W Morgans; Marla B Feller
Journal:  eNeuro       Date:  2020-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.